Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

When evaluating a subject’s brain structure volumes, looking at absolute volumes is the first step. However, naturally occurring variances due to age or gender might distort the impression these values provide. Differences in overall head size might distort the impression further, and result in questions such as: Is this hippocampus exceptionally small or is my patient’s overall brain size small and the smaller hippocampus is expected for somebody their age?

Normalizing the brain structure to the intracranial volume (ICV) adjusts for differences in overall head size; further restrictions of comparison to male and female subjects of a defined age provides even better results.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Using a normative data set established out of large population data gives context to the personalized brain structure volumes over a very broad age range. The WHO and CDC have been using normative reference charts for growth evaluations in children for many years. The same approach is used in the visualization of NeuroQuant®, results displaying an individual’s brain structure volume measurements relative to a healthy population. This allows NeuroQuant to deliver a precise impression of where that individual’s brain structure volume lies within an age- and gender- based reference chart, which aids physicians in their assessment of neurodegenerative conditions.

Cortechs.ai | Evaluating the Individual with the Power of Many: Using Normative Data in Personalized Medicine

Displaying the normalized patient brain structure volumes with reference to healthy cohorts based on age and gender is an integral part of NeuroQuant and a feature of each NeuroQuant report. Since launch in 2007, the NeuroQuant normative database has been continuously tested and validated against tens of thousands of clinical cases.

Want to learn more about Cortechs.ai Normative Database? Cortechs.ai has developed a Normative Database white paper, which is now available for download.

More Resources

06/16/2025

Seeing Alzheimer’s More Clearly: How PET Imaging Is Changing the Game

PET imaging is transforming how we detect and monitor Alzheimer’s disease, enabling earlier diagnosis, better disease tracking, and more personalized treatment.

06/11/2025

Cortechs.ai and RMS Medical Devices Forge Distribution Partnership to Expand Access to AI-Powered Imaging Solutions in the Benelux Region

We’re excited to announce our new partnership with RMS Medical Devices to our advanced neuroimaging and prostate imaging solutions to the Benelux region

06/04/2025

Cortechs.ai and deepc Announce Strategic Partnership to Advance AI Integration in Radiology

Press Release: Delivering Clinically Validated AI Solutions for Enhanced Imaging Precision and Workflow Efficiency

05/29/2025

Enhancing Imaging Workflow with DICOM SR: NeuroQuant®’s Seamless Integration 

As imaging becomes more data-driven, tools like NeuroQuant® with DICOM SR support pave the way for smarter, more connected radiology

05/18/2025

Cortechs.ai and ALZ-NET Announce Strategic Collaboration to Improve Alzheimer’s Disease Care Through AI-Driven Imaging

This new strategic collaboration aims to enhance the quality of care for people living with Alzheimer’s disease.

05/16/2025

Case Study: NeuroQuant® for ARIA: Monitoring ARIA Progression in Early Alzheimer’s Disease

Dr. Suzie Bash highlights how advanced imaging with NeuroQuant for ARIA supported detection and monitoring of ARIA-E and ARIA-H in an 81-year-old patient.
Scroll to Top